Current strategies to treat volumetric muscle loss use primarily pedicle or free muscle transfers, but these grafts fail to adequately regenerate functional tissue. Decellularized soft tissue grafts possess physical and chemical cues to promote muscle regeneration, suggesting their potential for use in large muscle defects. In this study, we developed a decellularized muscle matrix (DMM) graft using rat gastrocnemius. Anisotropy and chemical components of the extracellular matrix were retained, including laminin, fibronectin, and collagen. We compared the ability of DMM, autologous muscle grafts (clinical standard), and type I collagen plugs (negative control) to support muscle regeneration. DMM supported regeneration over a 56-day period in 1 × 1 cm and 1.5 × 1 cm gastrocnemius defects in rats. Muscle function tests demonstrated improved muscle recovery in rats with DMM grafts when compared to collagen. Histological sections were assessed using morphometrics and immunostaining. DMM supported muscle regeneration with less fibrosis and more de novo neuromuscular receptors than either autograft or collagen. Overall, our results indicate that DMM may be used as a muscle replacement graft based on its ability to improve muscle function recovery, promote muscle regeneration, and support new neuromuscular junctions.
Get full access to this article
View all access options for this article.
References
1.
GroganB.F., and HsuJ.R.Volumetric muscle loss. J Am Acad Orthop Surg, 19Suppl 1, S35, 2011.
2.
SayerN.A., CifuD.X., McNameeS., et al.Rehabilitation needs of combat-injured service members admitted to the VA polytrauma rehabilitation centers: the role of PM&R in the care of wounded warriors. PM R, 1, 23, 2009.
3.
RosenfeldJ.V., and FordN.L.Bomb blast, mild traumatic brain injury and psychiatric morbidity: a review. Injury, 41, 437, 2010.
4.
CriswellT.L., CoronaB.T., WardC.L., et al.Compression-induced muscle injury in rats that mimics compartment syndrome in humans. Am J Pathol, 180, 787, 2012.
5.
SiegelA.L., AtchisonK., FisherK.E., DavisG.E., and CornelisonD.D.W.3D timelapse analysis of muscle satellite cell motility. Stem Cells, 27, 2527, 2009.
GargK., CoronaB.T., and WaltersT.J.Losartan administration reduces fibrosis but hinders functional recovery after volumetric muscle loss injury. J Appl Physiol (1985), 117, 1120, 2014.
8.
WuX., CoronaB.T., ChenX., and WaltersT.J.A standardized rat model of volumetric muscle loss injury for the development of tissue engineering therapies. Biores Open Access, 1, 280, 2012.
9.
CoronaB.T., WardC.L., BakerH.B., WaltersT.J., and ChristG.J.Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury. Tissue Eng Part A, 20, 705, 2014.
10.
GargK., WardC.L., RathboneC.R., and CoronaB.T.Transplantation of devitalized muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after volumetric muscle loss injury. Cell Tissue Res, 358, 857, 2014.
11.
SwiderskiK., TodorovM., GehrigS.M., et al.Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice. Fibrogenesis Tissue Repair, 7, 1, 2014.
12.
VanDusenK.W., SyverudB.C., WilliamsM.L., LeeJ.D., and LarkinL.M.Engineered skeletal muscle units for repair of volumetric muscle loss in the tibialis anterior muscle of a rat. Tissue Eng Part A, 20, 2920, 2014.
13.
WangL., CaoL., ShanskyJ., WangZ., MooneyD., and VandenburghH.Minimally invasive approach to the repair of injured skeletal muscle with a shape-memory scaffold. Mol Ther, 22, 1441, 2014.
14.
ChenX.K., and WaltersT.J.Muscle-derived decellularised extracellular matrix improves functional recovery in a rat latissimus dorsi muscle defect model. J Plast Reconstr Aesthet Surg, 66, 1750, 2013.
15.
MachingalM.A., VishwajitS., BishwokarmaB., et al.Mouse latissimus dorsi as a model system for evaluating tissue engineered skeletal muscle. FASEB J, 23, 1, 2009.
16.
CarraroU., BoncompagniS., GobboV., et al.Persistent muscle fiber regeneration in long term denervation. past, present, future. Eur J Transl Myol, 25, 4832, 2015.
17.
LiM.T., WillettN.J., UhrigB.A., GuldbergR.E., and WarrenG.L.Functional analysis of limb recovery following autograft treatment of volumetric muscle loss in the quadriceps femoris. J Biomech, 47, 2013, 2014.
18.
CoronaB.T., WenkeJ.C., and WardC.L.Pathophysiology of volumetric muscle loss injury. Cells Tissues Organs, 202, 180, 2016.
19.
PerniconiB., ColettiD., AulinoP., et al.Muscle acellular scaffold as a biomaterial: effects on C2C12 cell differentiation and interaction with the murine host environment. Front Physiol, 5, 13, 2014.
20.
Van RyP.M., MinogueP., HodgesB.L., and BurkinD.J.Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy. Hum Mol Genet, 23, 383, 2014.
21.
PlantmanS.Proregenerative properties of ECM molecules. Biomed Res Int, 2013, 981695, 2013.
22.
WangL.N., JohnsonJ.A., ChangD.W., and ZhangQ.X.Decellularized musculofascial extracellular matrix for tissue engineering. Biomaterials, 34, 2641, 2013.
23.
RooneyJ.E., KnappJ.R., HodgesB.L., WuebblesR.D., and BurkinD.J.Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy. Am J Pathol, 180, 1593, 2012.
24.
NealR.A., McClugageS.G., LinkM.C., SefcikL.S., OgleR.C., and BotchweyE.A.Laminin nanofiber meshes that mimic morphological properties and bioactivity of basement membranes. Tissue Eng Part C Methods, 15, 11, 2009.
25.
RooneyJ.E., GurpurP.B., Yablonka-ReuveniZ., and BurkinD.J.Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy. Am J Pathol, 174, 256, 2009.
26.
AbrahamS., BrahimS., and Guiseppi-ElieA.Molecularly engineered hydrogels for implant biocompatibility. Conf Proc IEEE Eng Med Biol Soc, 7, 5036, 2004.
27.
BaileyS.B., EichlerM.E., VilladiegoA., and RichK.M.The influence of fibronectin and laminin during Schwann cell migration and peripheral nerve regeneration through silicon chambers. J Neurocytol, 22, 176, 1993.
28.
CalveS., and SimonH.G.Biochemical and mechanical environment cooperatively regulate skeletal muscle regeneration. FASEB J, 26, 2538, 2012.
29.
PerniconiB., CostaA., AulinoP., TeodoriL., AdamoS., and ColettiD.The pro-myogenic environment provided by whole organ scale acellular scaffolds from skeletal muscle. Biomaterials, 32, 7870, 2011.
30.
BadylakS., GilbertT., and Myers-IrvinJ.The extracellular matrix as a biologic scaffold for tissue enigneering. In: van BlitterswijkC., ThomsenP., LindahlA., HubbellJ., WilliamsD., CanceddaR., et al., eds. Tissue Engineering. First ed. London: Academic Press, 2008, p. 121.
31.
BadylakS.F.Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: factors that influence the host response. Ann Biomed Eng, 42, 1517, 2014.
MahoneyZ.X., StappenbeckT.S., and MinerJ.H.Laminin alpha 5 influences the architecture of the mouse small intestine mucosa. J Cell Sci, 121, 2493, 2008.
34.
ByronA., HumphriesJ.D., and HumphriesM.J.Defining the extracellular matrix using proteomics. Int J Exp Pathol, 94, 75, 2013.
35.
GilliesA.R., and LieberR.L.Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve, 44, 318, 2011.
36.
Farach-CarsonM.C., WagnerR.C., and KiickK.L.Extracellular matrix: structure, function, and applications to tissue engineering. In: FisherJ.P., MikosA.G., BronzinoJ.D., eds. Tissue Engineering. Boca Raton, FL: CRC Press, 2007, p. 3.
37.
Lagos-QuintanaM., RauhutR., YalcinA., MeyerJ., LendeckelW., and TuschlT.Identification of tissue-specific microRNAs from mouse. Curr Biol, 12, 735, 2002.
MurphyS., and OhlendieckK.The biochemical and mass spectrometric profiling of the dystrophin complexome from skeletal muscle. Comput Struct Biotechnol J, 14, 20, 2016.
40.
HuleihelL., HusseyG.S., NaranjoJ.D., et al.Matrix-bound nanovesicles within ECM bioscaffolds. Sci Adv, 2, e1600502, 2016.
41.
WolfM.T., DalyK.A., ReingJ.E., and BadylakS.F.Biologic scaffold composed of skeletal muscle extracellular matrix. Biomaterials, 33, 2916, 2012.
42.
FishmanJ.M., LowdellM.W., UrbaniL., et al.Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci USA, 110, 14360, 2013.
43.
AbmayrS.M., and PavlathG.K.Myoblast fusion: lessons from flies and mice. Development, 139, 641, 2012.
44.
HurmeT., KalimoH., LehtoM., and JarvinenM.Healing of skeletal muscle injury: an ultrastructural and immunohistochemical study. Med Sci Sports Exerc, 23, 801, 1991.
45.
MerrittE.K., CannonM.V., HammersD.W., et al.Repair of traumatic skeletal muscle injury with bone-marrow-derived mesenchymal stem cells seeded on extracellular matrix. Tissue Eng Part A, 16, 2871, 2010.
46.
MerrittE.K., HammersD.W., TierneyM., SuggsL.J., WaltersT.J., and FarrarR.P.Functional assessment of skeletal muscle regeneration utilizing homologous extracellular matrix as scaffolding. Tissue Eng Part A, 16, 1395, 2010.
47.
ErbM.Quantitative Determination of Muscle Fiber Diameter (Minimal Feret's Diameter) and Percentage of Centralized Nuclei. Treat NMD Wellstone Muscular Dystrophy Center; Newcastle upon Tyne, United Kingdom, 2008. p. 1.
48.
YuP., MatloubH.S., SangerJ.R., and NariniP.Gait analysis in rats with peripheral nerve injury. Muscle Nerve, 24, 231, 2001.
49.
ChaniaryK.D., BaronM.S., RiceA.C., WetzelP.A., RarnakrishnanV., and ShapiroS.M.Quantification of gait in dystonic Gunn rats. J Neurosci Methods, 180, 273, 2009.
50.
WolfM.T., VodovotzY., TotteyS., BrownB.N., and BadylakS.F.Predicting in vivo responses to biomaterials via combined in vitro and in silico analysis. Tissue Eng Part C-Methods, 21, 148, 2015.
51.
FaulkD.M., JohnsonS.A., ZhangL., and BadylakS.F.Role of the extracellular matrix in whole organ engineering. J Cell Physiol, 229, 984, 2014.
52.
LinC.H., YangJ.R., ChiangN.J., MaH., and TsayR.Y.Evaluation of decellularized extracellular matrix of skeletal muscle for tissue engineering. Int J Artif Organs, 37, 546, 2014.
53.
CharestJ.L., GarciaA.J., and KingW.P.Myoblast alignment and differentiation on cell culture substrates with microscale topography and model chemistries. Biomaterials, 28, 2202, 2007.
54.
PalamaI.E., ColucciaA.M.L., GigliG., and RiehleM.Modulation of alignment and differentiation of skeletal myoblasts by biomimetic materials. Integr Biol, 4, 1299, 2012.
55.
SunY., DuffyR., LeeA., and FeinbergA.W.Optimizing the structure and contractility of engineered skeletal muscle thin films. Acta Biomater, 9, 7885, 2013.
56.
GuexA.G., BirrerD.L., FortunatoG., TevaearaiH.T., and GiraudM.N.Anisotropically oriented electrospun matrices with an imprinted periodic micropattern: a new scaffold for engineered muscle constructs. Biomed Mater, 8, 021001, 2013.
57.
RicottiL., PoliniA., GenchiG.G., et al.Proliferation and skeletal myotube formation capability of C2C12 and H9c2 cells on isotropic and anisotropic electrospun nanofibrous PHB scaffolds. Biomed Mater, 7, 035010, 2012.
58.
HuberA., PickettA., and ShakesheffK.M.Reconstruction of spatially orientated myotubes in vitro using electrospun, parallel microfibre arrays. Eur Cell Mater, 14, 56, 2007.
59.
McClureM.J., GargK., SimpsonD.G., et al.The influence of platelet-rich plasma on myogenic differentiation. J Tissue Eng Regen Med, 19, 2013.
60.
McClureM.J., ClarkN.M., HyzyS.L., et al.Role of integrin alpha7beta1 signaling in myoblast differentiation on aligned polydioxanone scaffolds. Acta Biomater, 15, 44, 2016.
61.
BianW.N., and BursacN.Engineered skeletal muscle tissue networks with controllable architecture. Biomaterials, 30, 1401, 2009.
62.
JuhasM., EngelmayrG.C., FontanellaA.N., PalmerG.M., and BursacN.Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc Natl Acad Sci USA, 111, 5508, 2014.
63.
PalcheskoR.N., ZhangL., SunY., and FeinbergA.W.Development of polydimethylsiloxane substrates with tunable elastic modulus to study cell mechanobiology in muscle and nerve. PLos One, 7, e51499, 2012.
64.
TurnerN.J., and BadylakS.F.Biologic scaffolds for musculotendinous tissue repair. Euro Cells Mater, 25, 130, 2013.
65.
TurnerN.J., and BadylakS.F.Regeneration of skeletal muscle. Cell Tissue Res, 347, 759, 2012.
66.
MaseV.J.Jr., HsuJ.R., WolfS.E., et al.Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics, 33, 511, 2010.
67.
ValentinJ.E., TurnerN.J., GilbertT.W., and BadylakS.F.Functional skeletal muscle formation with a biologic scaffold. Biomaterials, 31, 7475, 2010.
68.
SicariB.M., RubinJ.P., DearthC.L., et al.An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss. Sci Transl Med, 6, 234ra58, 2014.
69.
DeQuachJ.A., LinJ.E., CamC., et al.Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model. Eur Cell Mater, 23, 400, 2012.
70.
ShahR., KnowlesJ.C., HuntN.P., and LewisM.P.Development of a novel smart scaffold for human skeletal muscle regeneration. J Tissue Eng Regen Med, 10, 162, 2016.
71.
DeriesM., GoncalvesA.B., VazR., MartinsG.G., RodriguesG., and ThorsteinsdottirS.Extracellular matrix remodeling accompanies axial muscle development and morphogenesis in the mouse. Dev Dyn, 241, 350, 2012.
72.
MorrisseyJ.B., ChengR.Y., DavoudiS., and GilbertP.M.Biomechanical origins of muscle stem cell signal transduction. J Mol Biol, 428, 1441, 2016.
73.
AlexakisC., PartridgeT., and Bou-GhariosG.Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol, 293, C661, 2007.
74.
GilbertT.W., SellaroT.L., and BadylakS.F.Decellularization of tissues and organs. Biomaterials, 27, 3675, 2006.
75.
GilbertT.W.Strategies for tissue and organ decellularization. J Cell Biochem, 113, 2217, 2012.
76.
BurkinD.J., WallaceG.Q., NicolK.J., KaufmanD.J., and KaufmanS.J.Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol, 152, 1207, 2001.
77.
ChipmanP.H., SchachnerM., and RafuseV.F.Presynaptic NCAM is required for motor neurons to functionally expand their peripheral field of innervation in partially denervated muscles. J Neurosci, 34, 10497, 2014.
78.
JonssonS., WibergR., McGrathA.M., et al.Effect of delayed peripheral nerve repair on nerve regeneration, Schwann cell function and target muscle recovery. PLoS One, 8, e56484, 2013.
79.
KoningM., HarmsenM.C., van LuynM.J., and WerkerP.M.Current opportunities and challenges in skeletal muscle tissue engineering. J Tissue Eng Regen Med, 3, 407, 2009.
80.
WitzemannV.Development of the neuromuscular junction. Cell Tissue Res, 326, 263, 2006.
81.
YampolskyP., GenslerS., McArdleJ., and WitzemannV.AChR channel conversion and AChR-adjusted neuronal survival during embryonic development. Mol Cell Neurosci, 37, 634, 2008.
82.
NishidaN., TaguchiA., MotoyoshiK., HyodoM., GyoK., and DesakiJ.Age-related changes in rat intrinsic laryngeal muscles: analysis of muscle fibers, muscle fiber proteins, and subneural apparatuses. Eur Arch Otorhinolaryngol, 270, 975, 2013.
83.
PetteD.The adaptive potential of skeletal muscle fibers. Can J Appl Physiol, 27, 423, 2002.
84.
FangZ.P., and MortimerJ.T.A method to effect physiological recruitment order in electrically activated muscle. IEEE Trans Biomed Eng, 38, 175, 1991.
NagesserA.S., van der LaarseW.J., and ElzingaG.Metabolic changes with fatigue in different types of single muscle fibres of Xenopus laevis. J Physiol, 448, 511, 1992.
87.
KupaE.J., RoyS.H., KandarianS.C., and De LucaC.J.Effects of muscle fiber type and size on EMG median frequency and conduction velocity. J Appl Physiol (1985), 79, 23, 1995.
88.
WardC.L., JiL., and CoronaB.T.An autologous muscle tissue expansion approach for the treatment of volumetric muscle loss. Biores Open Access, 4, 198, 2015.
89.
EnokaR.M., and DuchateauJ.Muscle fatigue: what, why and how it influences muscle function. J Physiol, 586, 11, 2008.
90.
CoronaB.T., WuX., WardC.L., McDanielJ.S., RathboneC.R., and WaltersT.J.The promotion of a functional fibrosis in skeletal muscle with volumetric muscle loss injury following the transplantation of muscle-ECM. Biomaterials, 34, 3324, 2013.
91.
MounierR., ChretienF., and ChazaudB.Blood vessels and the satellite cell niche. Curr Top Dev Biol, 96, 121, 2011.
92.
LagordC., SouletL., BonavaudS., et al.Differential myogenicity of satellite cells isolated from extensor digitorum longus (EDL) and soleus rat muscles revealed in vitro. Cell Tissue Res, 291, 455, 1998.
93.
ArmstrongR.B., and PhelpsR.O.Muscle fiber type composition of the rat hindlimb. Am J Anat, 171, 259, 1984.
94.
GibsonM.C., and SchultzE.The distribution of satellite cells and their relationship to specific fiber types in soleus and extensor digitorum longus muscles. Anat Rec, 202, 329, 1982.
95.
BeermannD.H., HoodL.F., and LiboffM.Satellite cell and myonuclei populations in rat soleus and extensor digitorum longus muscles after maternal nutritional deprivation and realimentation. J Anim Sci, 57, 1618, 1983.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
